FDA Supports Qualified Health Claim for Magnesium and Reduced Hypertension Risk
The strength of the scientific evidence supporting the relationship will be disclosed as “supportive but inconclusive” to avoid misleading consumers.
Cardiology
Possible Defective Delivery System Prompts Recall of Nitroglycerin Lingual Spray
Nitroglycerin Lingual Spray is indicated for the acute relief of an attack or prophylaxis of chest pain due to coronary artery disease in adult patients.
Aficamten Gets Breakthrough Tx Status for Obstructive Hypertrophic Cardiomyopathy
The designation was based on data from the phase 2 REDWOOD-HCM trial.
Drugs Prescribed Widely for Common Conditions Linked to Orthostatic Hypotension
The meta-analysis included 69 RCTs with a total of 27,079 patients.
Does Calling a Colleague Physician an “Idiot” Constitute Defamation?
After his clinical privileges at the hospital were revoked, Dr S filed a lawsuit against numerous individuals involved in the peer review process.
Obstructive Sleep Apnea May Raise Risk for Sudden Death
Meta-analysis shows sleep apnea linked to increased risk for sudden death, cardiovascular mortality
Udenafil Under Review for Single Ventricle Heart Disease
The NDA submission is supported by data from more than 200 studies completed over the last 2 decades, including the pivotal phase 3 FUEL trial.
Gene Therapy Gets Orphan Drug Status for Genetic Hypertrophic Cardiomyopathy
TN-201 is a potentially curative, one-time, AAV-based gene therapy to address genetic hypertrophic cardiomyopathy caused by MYBPC3 gene mutations.
Weight Loss Supplement Recalled Due to Presence of Stimulant
DMAA constricts blood vessels and arteries, leading to increased blood pressure and cardiovascular problems.
FDA: Consumer Electronics May Impact Implanted Medical Devices
The FDA is advising patients with implanted medical devices to consider keeping consumer electronics at least 6 inches away from the implanted medical device.
